Flowers Foods (FLO) Q1 2026 (Q&A) earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 (Q&A) earnings summary
23 May, 2026Executive summary
Net sales rose 1.1% year-over-year to $1.572 billion, driven by the Simple Mills acquisition and favorable pricing/mix, offsetting volume declines.
Net income fell 20.6% to $42.1 million, with adjusted net income down 17.4% to $60.9 million, reflecting higher costs, legal settlements, and a challenging consumer environment.
Adjusted EBITDA decreased 1.8% to $159.0 million, representing 10.1% of net sales.
Strategic review of brand portfolio, supply chain, and financial strategy is underway, with a sharpened focus on core brands and better-for-you segments.
Relaunch of Nature's Own with a clean-label, non-GMO formula and national marketing campaign demonstrates investment in leading brands.
Financial highlights
Net sales: $1.572 billion (+1.1% year-over-year); Branded Retail net sales up 3.4% to $1.045 billion, driven by pricing/mix and acquisition, despite a 4.2% volume decline.
Net income: $42.1 million (-20.6% year-over-year); adjusted EBITDA: $159.0 million (10.1% margin); EPS: $0.20 (down $0.05); adjusted diluted EPS: $0.29 (down $0.06).
Operating income: $79.8 million (-6.3% year-over-year); cash from operations: $107.9 million; capital expenditures: $20.6 million.
Dividend reset to $0.50 per share annually to support deleveraging and balance sheet flexibility.
Cash and cash equivalents at quarter end: $11.5 million; total available liquidity: $1.07 billion.
Outlook and guidance
Fiscal 2026 net sales expected between $5.163 billion and $5.267 billion, a change of -1.8% to 0.2% year-over-year.
Adjusted EBITDA guidance: $465 million to $495 million; adjusted diluted EPS: $0.80 to $0.90.
Fully hedged on core commodities for 2026, with cost increases in packaging and oil derivatives factored into guidance.
Capital expenditures expected at $115 million to $125 million, including $4 million–$8 million for ERP upgrade.
Reaffirmed full-year outlook despite incremental cost headwinds and a more challenging top-line environment.
Latest events from Flowers Foods
- Net income fell 27.4% as sales declined, but adjusted EBITDA rose 1.6% on margin gains.FLO
Q1 2025 Prepared Remarks22 May 2026 - Net sales up 1.1% but net income down 20.6% amid higher costs and market challenges.FLO
Q1 2026 Prepared Remarks21 May 2026 - Shareholders to vote on directors, executive pay, auditor, and new equity plan amid strong results.FLO
Proxy filing14 Apr 2026 - Key votes include director elections, executive pay, auditor ratification, and a new incentive plan.FLO
Proxy filing14 Apr 2026 - Q4 sales up 11% but net loss from impairment; 2026 outlook flat amid headwinds.FLO
Q4 2025 (Q&A)12 Apr 2026 - Q4 sales up 11% but net loss from $136M impairment; 2026 outlook cautious amid headwinds.FLO
Q4 2025 Prepared Remarks25 Feb 2026 - Net income rose to $65M as branded bread outperformed and margins improved despite lower sales.FLO
Q3 2024 (Q&A)3 Feb 2026 - Net income up 5% and EBITDA up 7.8% on margin gains, despite flat sales and ongoing cost pressures.FLO
Q2 2024 (Q&A)23 Jan 2026 - Net income and margins rose in Q2 2024, with FY guidance reaffirmed and cost savings ongoing.FLO
Q2 2024 Prepared Remarks23 Jan 2026